Healthcare provider profile · identity verified

Patrick Luft

Family Practice · DENISON, IA · NPI 1508420027

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	391	124
Omeprazole	Omeprazole	286	90
Levothyroxine Sodium	Levothyroxine Sodium	270	88
Tamsulosin Hcl	Tamsulosin Hcl	224	62
Lisinopril	Lisinopril	216	63
Metoprolol Succinate	Metoprolol Succinate	216	70
Amlodipine Besylate	Amlodipine Besylate	207	76
Losartan Potassium	Losartan Potassium	206	64
Metoprolol Tartrate	Metoprolol Tartrate	171	38
Furosemide	Furosemide	165	64
Metformin Hcl	Metformin Hcl	163	42
Gabapentin	Gabapentin	143	46
Eliquis	Apixaban	138	34
Tramadol Hcl	Tramadol Hcl	123	50
Celecoxib	Celecoxib	115	41
Metformin Hcl Er	Metformin Hcl	113	39
Sertraline Hcl	Sertraline Hcl	110	25
Hydrochlorothiazide	Hydrochlorothiazide	107	38
Potassium Chloride	Potassium Chloride	107	41
Pantoprazole Sodium	Pantoprazole Sodium	100	32
Prednisone	Prednisone	92	71
Meloxicam	Meloxicam	87	30
Albuterol Sulfate Hfa	Albuterol Sulfate	84	34
Doxycycline Hyclate	Doxycycline Hyclate	81	71
Jardiance	Empagliflozin	80	18
Ozempic	Semaglutide	80	18
Citalopram Hbr	Citalopram Hydrobromide	78	20
Clopidogrel	Clopidogrel Bisulfate	78	29
Xarelto	Rivaroxaban	77	18
Simvastatin	Simvastatin	76	24
Glipizide Er	Glipizide	75	29
Cephalexin	Cephalexin	74	60
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	14
Allopurinol	Allopurinol	73	13
Glipizide	Glipizide	68	18
Trazodone Hcl	Trazodone Hcl	65	22
Duloxetine Hcl	Duloxetine Hcl	62	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	28
Zolpidem Tartrate	Zolpidem Tartrate	59	14
Rosuvastatin Calcium	Rosuvastatin Calcium	58	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	58	46
Fluticasone Propionate	Fluticasone Propionate	56	12
Bupropion Xl	Bupropion Hcl	54	11
Carvedilol	Carvedilol	53	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	22
Escitalopram Oxalate	Escitalopram Oxalate	52	16
Fluoxetine Hcl	Fluoxetine Hcl	52	13
Methylprednisolone	Methylprednisolone	52	47
Myrbetriq	Mirabegron	51	suppressed
Famotidine	Famotidine	49	suppressed
Lorazepam	Lorazepam	49	20
Warfarin Sodium	Warfarin Sodium	49	13
Risperidone	Risperidone	47	suppressed
Azithromycin	Azithromycin	45	42
Jantoven	Warfarin Sodium	44	suppressed
Buspirone Hcl	Buspirone Hcl	42	13
Alendronate Sodium	Alendronate Sodium	41	15
Levetiracetam	Levetiracetam	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	40	26
Donepezil Hcl	Donepezil Hcl	39	suppressed
Finasteride	Finasteride	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	29
Baclofen	Baclofen	36	13
Quetiapine Fumarate	Quetiapine Fumarate	34	13
Ropinirole Hcl	Ropinirole Hcl	34	12
Dicyclomine Hcl	Dicyclomine Hcl	33	suppressed
Trulicity	Dulaglutide	32	11
Pregabalin	Pregabalin	31	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Amoxicillin	Amoxicillin	29	25
Montelukast Sodium	Montelukast Sodium	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	20
Dutasteride	Dutasteride	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Methotrexate	Methotrexate Sodium	27	suppressed
Diltiazem Hcl	Diltiazem Hcl	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Bumetanide	Bumetanide	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Mesalamine	Mesalamine	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Nystatin	Nystatin	22	16
Levofloxacin	Levofloxacin	21	20
Pravastatin Sodium	Pravastatin Sodium	21	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Dexamethasone	Dexamethasone	20	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Dexlansoprazole Dr	Dexlansoprazole	19	suppressed
Fentanyl	Fentanyl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Diclofenac Potassium	Diclofenac Potassium	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Atenolol	Atenolol	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error